Performant Financial Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$PFMT
Other Consumer Services
Consumer Discretionary
Get the next $PFMT alert in real time by email
pfmt-20241106
0001550695FALSE00015506952024-11-062024-11-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 6, 2024 
 
Performant Financial Corporation
(Exact name of registrant as specified in its charter)

Delaware 001-35628 20-0484934
(State or other jurisdiction
of incorporation)
 (Commission
File Number)
 (IRS Employer
Identification No.)
900 South Pine Island Road,
Plantation, FL 33324
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (925)  960-4800

N/A
(Former name or former address, if changed since last report.)
 
 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§ 240.12b–2 of this chapter).     

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s) Name of exchange on which registered
Common Stock, par value $.0001 per share
PFMT
The Nasdaq Stock Market LLC



Item 2.02Results of Operations and Financial Condition.
On November 6, 2024 Performant Financial Corporation issued a press release announcing financial results for its quarter ended September 30, 2024. The full text of the press release is furnished as Exhibit 99.1.
The information furnished in this Form 8-K, including the exhibit attached, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and it shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01Financial Statements and Exhibits.
(d)Exhibits
99.1   
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 6, 2024
 
PERFORMANT FINANCIAL CORPORATION
By: /s/Rohit Ramchandani
 Rohit Ramchandani
 Chief Financial Officer

Get the next $PFMT alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PFMT

DatePrice TargetRatingAnalyst
7/25/2024$8.00Buy
B. Riley Securities
12/20/2022$8.00Buy
Lake Street
4/11/2022$8.00Buy
Lake Street
7/7/2021$10.00Buy
Craig Hallum
More analyst ratings

$PFMT
Press Releases

Fastest customizable press release news feed in the world

See more
  • Performant Healthcare, Inc. Ticker Symbol Change to "PHLT"

    Performant Healthcare, Inc. (NASDAQ:PFMT) ("Performant" or the "Company") is pleased to announce that its ticker symbol on the Nasdaq stock exchange will change from "PFMT" to "PHLT" effective as of market open on Wednesday, December 18, 2024. The change reflects Performant's strategic evolution into a pure-play healthcare payment integrity leader, underscoring its commitment to providing innovative solutions that reduce waste and abuse in the healthcare system. The transition to "PHLT" requires no action from shareholders. Performant's common shares will continue to be listed on Nasdaq with no changes to the CUSIP number, GICS, and NAICS codes associated with the Company's common stock

    $PFMT
    Other Consumer Services
    Consumer Discretionary
  • Performant Announces Name Change to Performant Healthcare, Inc. – Concludes Strategic Shift to Healthcare

    New Nasdaq Ticker Symbol Will Be PHLT Performant Financial Corporation (NASDAQ:PFMT) today announced it has changed its name to Performant Healthcare, Inc. ("Performant" or the "Company"), and plans to update its ticker symbol to PHLT. The name change and new ticker symbol will not impact the Company's operations, management or structure. Performant, a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, is changing its name to reflect its strategic commitment to becoming a pure-play leader in healthcare payment integrity. "The name Performant Healthcare, Inc. reflects our commitment to delivering world-class payment integrity solution

    $PFMT
    Other Consumer Services
    Consumer Discretionary
  • Performant to Participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference

    Performant Financial Corporation (NASDAQ:PFMT) (the "Company"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that it will participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference, taking place in Boca Raton on Tuesday, December 3rd. Simeon Kohl, CEO, will present and meet with investors to discuss key updates, including the recent New York State Medicaid RAC award, progress on efficiency initiatives aimed at margin improvement, successful commercial implementations and a robust pipeline, and upcoming government opportunities. We're excited to share these developments as we continue dr

    $PFMT
    Other Consumer Services
    Consumer Discretionary

$PFMT
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$PFMT
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$PFMT
SEC Filings

See more

$PFMT
Leadership Updates

Live Leadership Updates

See more
  • Performant Financial Corporation Announces the Appointment of Dr. Shantanu Agrawal to Its Board of Directors

    Performant Financial Corporation (NASDAQ:PFMT) (Performant), primarily operating as Performant Healthcare Solutions, a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, is proud to announce the appointment of Dr. Shantanu Agrawal, M.D. to its Board of Directors. Dr. Agrawal brings a wealth of expertise and experience in healthcare policy and payment integrity. As Chief Health Officer at Elevance Health (NYSE:ELV), Dr. Agrawal oversees the whole health strategy, including medical policy and clinical quality, as well as the community health strategy and Elevance Health Foundation. Prior to Elevance Health, Dr. Agrawal held numerous execut

    $ELV
    $PFMT
    Medical Specialities
    Health Care
    Other Consumer Services
    Consumer Discretionary

$PFMT
Financials

Live finance-specific insights

See more
  • Performant Financial Corporation Announces Financial Results for Third Quarter 2024

    Performant Financial Corporation (NASDAQ:PFMT), a leading provider of healthcare payment integrity services, today reported the following financial results for its third quarter ended September 30, 2024: Third Quarter Financial Highlights Healthcare revenues of $30.3 million, compared to $28.5 million in the prior year period, an increase of approximately 6%. Total revenues of $31.5 million, compared to total revenues of $30.0 million in the prior year period. Net loss of $2.4 million, or $(0.03) per diluted share, compared to net loss of $0.6 million, or $(0.01) per diluted share, in the prior year period. Adjusted EBITDA of $1.9 million, compared to $1.8 million in the prior year

    $PFMT
    Other Consumer Services
    Consumer Discretionary
  • Performant Financial Corporation to Report Third Quarter 2024 Earnings on November 6, 2024

    Performant Financial Corporation (NASDAQ:PFMT) (the Company), primarily operating under subsidiary Performant Healthcare Solutions, a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that the company will report its third quarter 2024 results after the market closes Wednesday November 6, 2024. The Company will also hold a conference call to discuss results at 5:00 pm (Eastern Time) that day. To join the conference call: Dial in 800-717-1738 or 646-307-1865, or Live webcast through company's website here Replay can be found approximately three hours after the call on the company website under the Events & Presentations

    $PFMT
    Other Consumer Services
    Consumer Discretionary
  • Performant Financial Corporation Announces Financial Results for Second Quarter 2024

    Performant Financial Corporation (NASDAQ:PFMT), a leading provider of healthcare payment integrity services, today reported the following financial results for its second quarter ended June 30, 2024: Second Quarter Financial Highlights Healthcare revenues of $27.9 million, compared to $23.9 million in the prior year period, an increase of approximately 17%. Total revenues of $29.4 million, compared to total revenues of $25.5 million in the prior year period. Net loss of $3.0 million, or $(0.04) per diluted share, compared to net loss of $4.0 million, or $(0.05) per diluted share, in the prior year period. Adjusted EBITDA of $0.5 million, compared to $(1.3) million in the prior

    $PFMT
    Other Consumer Services
    Consumer Discretionary

$PFMT
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more